17th World ADC San Diego Summit

The 17th World ADC San Diego Summit takes over the Town and Country Resort starting Monday, October 12, 2026. It's the global antibody-drug conjugate community coming to San Diego for a few days of case studies, development trends, and networking. The summit runs from 8 AM on Monday through 6 PM on Thursday, October 15, so it's a full four-day stretch.

This year's theme is 'Redefining Early-Line Oncology Patient Impact,' and the program is built around seven end-to-end streams: Discovery Chemistry, Discovery Biology, Preclinical, Translational Medicine, Clinical Lessons, Process and Analytical Development, and Manufacturing and Supply. It's designed as a one-stop bioconjugate shop, covering the whole pipeline from the early chemistry and biology to the clinical results and the actual manufacturing. The room usually gathers around 1,300 senior industry figures—people from big biopharma, innovative start-ups, service providers, and academic, physician, and regulator key opinion leaders.

The lineup of speakers includes Jack Chen from AbbVie, Petra Dieterich from Abzena, Sonia Appel from Alismere, Suzanne Edavettal and Herbert Ogutu from Amgen, and Vinod Bulusu from AstraZeneca, with more coming from Bristol Myers Squibb, Genentech, Pfizer, Regeneron, and Daiichi Sankyo. Between the seven streams, you'll find a mix of case studies and discussions on where the field is heading.

Registration is tiered based on what you want to attend: the Conference plus a Seminar Day is $4,248, and the Conference plus a Workshop Day is also $4,248. If you want both the Seminar and Workshop days, it's $5,297. There's an Academic rate of $3,697 and a Vendor rate of $6,297. The summit is at the Town and Country Resort, 500 Hotel Circle North, San Diego, California 92108.